Aspire Biopharma Holdings. We are moving with speed to transform our clinical pipeline into commercial reality, broadening the market reach of our high growth consumer segment, while simultaneously ...
Aspire Biopharma Holdings (NASDAQ:ASBP) is one of the worst performing NASDAQ stocks so far in 2026. On April 27, Aspire Biopharma authorized a $5 million share repurchase program using existing cash.
HARRISBURG, Pa. (WHTM) — The year just started, but some are looking ahead to new opportunities. Penn Medicine’s ASPIRE program plans to help students in Pennsylvania with career aspirations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results